The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation

Academic Article


  • Mesalamine serves as the gold standard in treating ulcerative colitis. However, its precise mechanism(s) of action remains unclear. Here, we show that mesalamine treatment rapidly decreases polyphosphate levels in diverse bacteria, including members of the human gut microbiome. This decrease sensitizes bacteria towards oxidative stress, reduces colonization and attenuates persister cell and biofilm formation, suggesting that mesalamine aids in diminishing the capacity of bacteria to persist within chronically inflamed environments.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Dahl JU; Gray MJ; Bazopoulou D; Beaufay F; Lempart J; Koenigsknecht MJ; Wang Y; Baker JR; Hasler WL; Young VB
  • Volume

  • 2